XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.65

+3.2%

1:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (11377)	8/18/1999 8:55:00 PM
From: Cacaito	Read Replies (1) of 17367

George w, the trauma trial could give very good answers with 800 plus patients if the previous 400 patients trial is confirmed, a statistically significant decrease in pneumonia /ards complications. The numbers are more than enough for that purpose. Decrease in mortality/ventilator days/hospital days/costs was not significant in the FOUR HUNDRED patients trial and to show the desired results in 800 or 1600 is less likely than good results in the Meningo trial (my view, of course).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next